Atara Biotherapeutics
ATRA
#9539
Rank
NZ$0.15 B
Marketcap
NZ$16.96
Share price
3.08%
Change (1 day)
10.84%
Change (1 year)

Market capitalization of Atara Biotherapeutics (ATRA)

Market cap: NZ$0.15 Billion

As of June 2026 Atara Biotherapeutics has a market cap of NZ$0.15 Billion. This makes Atara Biotherapeutics the world's 9539th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atara Biotherapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.15 B-28.92%
2025NZ$0.21 B73.27%
2024NZ$0.12 B50.14%
2023NZ$82.64 M-83.14%
2022NZ$0.49 B-76.83%
2021NZ$2.11 B-6.75%
2020NZ$2.26 B63.27%
2019NZ$1.38 B-41.63%
2018NZ$2.37 B205.2%
2017NZ$0.77 B31.8%
2016NZ$0.59 B-46.12%
2015NZ$1.09 B63.33%
2014NZ$0.67 B

End of Day market cap according to different sources

On Jun 8th, 2026 the market cap of Atara Biotherapeutics was reported to be:

NZ$0.14 Billion
by Nasdaq info icon info icon
NZ$0.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ImmunoGen
IMGN
NZ$14.98 B 9,705.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.22 B 48.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
NZ$5.11 M-96.66%๐Ÿ‡ฉ๐Ÿ‡ช Germany